[Clinical experience with ambroxol syrup (author's transl)].

Abstract

In an open trial trans-4-[(2-amino-3,5-dibromo-benzyl)-amino]-cyclohexanol hydrochloride (ambroxol, NA 872) in the form of ambroxol syrup was given to non-hospitalised patients suffering from acute and chronic bronchitis. A marked reduction in coughing and dyspnoea as well as an improvement in expectoration was apparent. The maximum effect was reached on the third day of treatment. The effect can be maintained by consistent prolongation of the therapy. There were no side effects.

• Authors: P Göbel, H Rensch
• Journal: Arzneimittel-Forschung (Arzneimittelforschung) Vol. 28 Issue 5a Pg. 929-31 ( 1978) ISSN: 0004-4172 [Print] Germany
• Vernacular Title: Klinische Erfahrungen mit Ambroxol-Saft.
• PMID: 581992 (Publication Type: English Abstract, Journal Article)

Chemical References

• Solutions
• Ambroxol
• Bromhexine

Topics

• Administration, Oral
• Adult
• Aged
• Ambroxol (administration & dosage, therapeutic use)
• Bromhexine (analogs & derivatives)
• Bronchitis (drug therapy)
• Female
• Humans
• Male
• Middle Aged
• Solutions
• Time Factors